These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22971058)

  • 1. Novel selective allosteric and bitopic ligands for the S1P(3) receptor.
    Jo E; Bhhatarai B; Repetto E; Guerrero M; Riley S; Brown SJ; Kohno Y; Roberts E; Schürer SC; Rosen H
    ACS Chem Biol; 2012 Dec; 7(12):1975-83. PubMed ID: 22971058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.
    Gonzalez-Cabrera PJ; Jo E; Sanna MG; Brown S; Leaf N; Marsolais D; Schaeffer MT; Chapman J; Cameron M; Guerrero M; Roberts E; Rosen H
    Mol Pharmacol; 2008 Nov; 74(5):1308-18. PubMed ID: 18708635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sphingosine 1-phosphate receptor 2 selective allosteric agonist.
    Satsu H; Schaeffer MT; Guerrero M; Saldana A; Eberhart C; Hodder P; Cayanan C; Schürer S; Bhhatarai B; Roberts E; Rosen H; Brown SJ
    Bioorg Med Chem; 2013 Sep; 21(17):5373-82. PubMed ID: 23849205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor.
    Holdsworth G; Osborne DA; Pham TT; Fells JI; Hutchinson G; Milligan G; Parrill AL
    BMC Biochem; 2004 Aug; 5():12. PubMed ID: 15298705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.
    Schürer SC; Brown SJ; Gonzalez-Cabrera PJ; Schaeffer MT; Chapman J; Jo E; Chase P; Spicer T; Hodder P; Rosen H
    ACS Chem Biol; 2008 Aug; 3(8):486-98. PubMed ID: 18590333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays.
    Riddy DM; Stamp C; Sykes DA; Charlton SJ; Dowling MR
    Br J Pharmacol; 2012 Oct; 167(4):868-80. PubMed ID: 22577868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
    Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
    Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
    Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
    J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor.
    Keov P; López L; Devine SM; Valant C; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
    J Biol Chem; 2014 Aug; 289(34):23817-37. PubMed ID: 25006252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.
    Kennedy PC; Zhu R; Huang T; Tomsig JL; Mathews TP; David M; Peyruchaud O; Macdonald TL; Lynch KR
    J Pharmacol Exp Ther; 2011 Sep; 338(3):879-89. PubMed ID: 21632869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
    Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.
    Murakami A; Takasugi H; Ohnuma S; Koide Y; Sakurai A; Takeda S; Hasegawa T; Sasamori J; Konno T; Hayashi K; Watanabe Y; Mori K; Sato Y; Takahashi A; Mochizuki N; Takakura N
    Mol Pharmacol; 2010 Apr; 77(4):704-13. PubMed ID: 20097776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 (Gilenya) phosphate selectivity of sphingosine 1-phosphate receptor subtype 1 (S1P1) G protein-coupled receptor requires motifs in intracellular loop 1 and transmembrane domain 2.
    Valentine WJ; Godwin VI; Osborne DA; Liu J; Fujiwara Y; Van Brocklyn J; Bittman R; Parrill AL; Tigyi G
    J Biol Chem; 2011 Sep; 286(35):30513-30525. PubMed ID: 21719706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)).
    Jongsma M; van Unen J; van Loenen PB; Michel MC; Peters SL; Alewijnse AE
    Br J Pharmacol; 2009 Apr; 156(8):1305-11. PubMed ID: 19309361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitoylation of the sphingosine 1-phosphate receptor S1P is involved in its signaling functions and internalization.
    Ohno Y; Ito A; Ogata R; Hiraga Y; Igarashi Y; Kihara A
    Genes Cells; 2009 Aug; 14(8):911-23. PubMed ID: 19619245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D
    Draper-Joyce CJ; Michino M; Verma RK; Klein Herenbrink C; Shonberg J; Kopinathan A; Scammells PJ; Capuano B; Thal DM; Javitch JA; Christopoulos A; Shi L; Lane JR
    Biochem Pharmacol; 2018 Feb; 148():315-328. PubMed ID: 29325769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P.
    Fujii Y; Ohtake H; Ono N; Hara T; Sakurai T; Takahashi S; Takayama T; Fukasawa Y; Shiozawa F; Tsukahara N; Hirayama T; Igarashi Y; Goitsuka R
    Biochim Biophys Acta; 2012 Apr; 1821(4):600-6. PubMed ID: 22265714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
    Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
    Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.